U.S. Capital Wealth Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-425
Closed -$4.24K 705
2022
Q4
$4.24K Buy
+425
New +$4.72K ﹤0.01% 1407

Other funds holding AXGN

U.S. Capital Wealth Advisors's AXGN Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Axogen (AXGN) in Q1 2023, closing a stake of 425 shares — an estimated $4.24K sold.

U.S. Capital Wealth Advisors first reported a position in AXGN in Q4 2022 and held it in 1 quarter. The position peaked at $4.24K in Q4 2022. 130 funds tracked by Wall St. Rank hold AXGN as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Axogen position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 425 Axogen shares in Q1 2023, an estimated $4.24K.
  • U.S. Capital Wealth Advisors first reported a position in Axogen in Q4 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Axogen position peaked at $4.24K in Q4 2022.
  • 130 funds tracked by Wall St. Rank held Axogen as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.